Hexarelin Protects Neuro-2A Cells from Hydrogen Peroxide-Induced Apoptosis by Modulating MAPK and PI3K/Akt Pathways
Background
Hydrogen peroxide (H2O2) is a common reactive oxygen species used in vitro to model oxidative stress, which leads to cellular damage and apoptosis (programmed cell death). This process is implicated in numerous neurodegenerative diseases. While the synthetic hexapeptide hexarelin is known for its cyto-protective effects in cardiac and skeletal muscle, its potential neuroprotective activities are less understood. Prior work has shown it acts at the mitochondrial level, suggesting it might counter oxidative stress-induced damage in neuronal cells as well. This study investigates if hexarelin can inhibit H2O2-induced apoptosis in nerve cells, potentially offering a new therapeutic avenue by exploring its impact on key cell survival and death pathways like MAPK and PI3K/Akt and apoptotic regulators like the BCL-2 family and caspases.
Study Design
This in vitro study used the Neuro-2A cell line. Cells were treated for 24 hours with various concentrations of hydrogen peroxide (H2O2) to induce apoptosis. A separate group was treated with a combination of H2O2 and hexarelin. Researchers measured cell viability and nitrite (NO2-) release. They also documented and quantified changes in cell morphology using Image J skeleton and fractal analysis. To evaluate apoptosis, the team used Real-Time PCR to measure mRNA levels of caspase-3, caspase-7, Bax, and Bcl-2, and Western Blot analysis to assess protein levels of cleaved caspase-3, cleaved caspase-7, MAPK, and Akt.
Results
Hexarelin treatment effectively counteracted the cellular damage induced by H2O2 in Neuro-2A cells. The peptide significantly improved cell viability, reduced the release of nitrite (NO2-), and restored the cells to their normal morphologies after being damaged by oxidative stress. On a molecular level, hexarelin demonstrated potent anti-apoptotic effects.
The study found that hexarelin treatment reduced mRNA levels of
caspase-3and inhibited its activation. It also beneficially modulated the mRNA levels of the pro-apoptoticBaxand anti-apoptoticBcl-2genes, which are critical regulators of the cell death process.
Furthermore, hexarelin's protective mechanism involved the modulation of key signaling pathways. It inhibited the phosphorylation of MAPKs (mitogen-activated protein kinases), a pathway often associated with stress responses and apoptosis. Concurrently, it increased the expression of phosphorylated Akt (p-Akt), a central protein in the PI3K/Akt pathway known for promoting cell survival and inhibiting apoptosis.
Key Findings
- Hexarelin improved cell viability in Neuro-2A cells exposed to H2O2-induced oxidative stress.
- The peptide reduced nitrite (NO2-) release, an indicator of cellular damage, in treated cells.
- Hexarelin treatment decreased mRNA levels and activation of executioner caspases, such as caspase-3.
- The mechanism involved inhibiting MAPKs phosphorylation while increasing p-Akt protein expression.
- Hexarelin beneficially modulated mRNA levels of the BCL-2 family of apoptosis-regulating genes.
Why It Matters
These findings establish that hexarelin has direct neuroprotective and anti-apoptotic effects in a cellular model of oxidative stress. For researchers and biohackers interested in neuroprotection, this suggests hexarelin may help shield neurons from damage, a mechanism relevant to both acute injury and chronic neurodegeneration. The results specifically highlight its ability to favorably modulate the MAPK and PI3K/Akt pathways, providing a clear mechanistic rationale for its effects. The key takeaway is that hexarelin's benefits extend beyond muscle tissue to the nervous system, potentially making it a candidate for protocols aimed at cognitive health and neuronal resilience. This is an early, in vitro study, so direct human application is distant. However, it strongly supports the development of new hexarelin analogues specifically optimized for neuroprotective efficacy, opening a new front for peptide-based therapies targeting brain health.
